Factors Associated With Pulmonary Embolism Among Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: A Multicenter Study Among 375 Patients
- PMID: 32766562
- PMCID: PMC7339309
- DOI: 10.1097/CCE.0000000000000166
Factors Associated With Pulmonary Embolism Among Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: A Multicenter Study Among 375 Patients
Abstract
Risk factors associated with pulmonary embolism in coronavirus disease 2019 acute respiratory distress syndrome patients deserve to be better known. We therefore performed a post hoc analysis from the COronaVirus-Associated DIsease Study (COVADIS) project, a multicenter observational study gathering 21 ICUs from France (n = 12) and Belgium (n = 9). Three-hundred seventy-five consecutive patients with moderate-to-severe acute respiratory distress syndrome and positive coronavirus disease 2019 were included in the study. At day 28, 15% were diagnosed with pulmonary embolism. Known risk factors for pulmonary embolism including cancer, obesity, diabetes, hypertension, and coronary artery disease were not associated with pulmonary embolism. In the multivariate analysis, younger age (< 65 yr) (odds ratio, 2.14; 1.17-4.03), time between onset of symptoms and antiviral administration greater than or equal to 7 days (odds ratio, 2.39; 1.27-4.73), and use of neuromuscular blockers greater than or equal to 7 days (odds ratio, 1.89; 1.05-3.43) were independently associated with pulmonary embolism. These new findings reinforce the need for prospective studies that will determine the predictors of pulmonary embolism among patients with severe coronavirus disease 2019.
Keywords: acute respiratory distress syndrome; coronavirus disease 2019; critically ill; pulmonary embolism; severe acute respiratory syndrome coronavirus 2; thrombotic complications.
Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.
Conflict of interest statement
Dr. Textoris is a part-time employee of bioMérieux, an IV diagnostics company, and Hospices Civils de Lyon, a university hospital. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Figures
References
-
- Helms J, Tacquard C, Severac F, et al. ; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med. 2020; 46:1089–1098 - PMC - PubMed
-
- Marini JJ. Dealing with the CARDS of COVID-19. Crit Care Med. 2020. May 13[online ahead of print] - PubMed
-
- Ranieri VM, Rubenfeld GD, Thompson BT, et al. ; ARDS Definition Task Force Acute respiratory distress syndrome: The Berlin definition. JAMA. 2012; 307:2526–2533 - PubMed
-
- Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019; 54:1901647. - PubMed
LinkOut - more resources
Full Text Sources
